Non Hodgkin’s lymphoma represents a group of cancers, which is characterized by twenty distinct clinical diseases that involve T or B lymphocytes. Non Hodgkin’s Lymphoma usually involves various lymph nodes in the neck, under arms or groin. CHOP is the most commonly used chemotherapy regimen for the treatment and management of Non Hodgkin’s lymphomas. CHOP has been known to cure these types of cancers or increase the chances of survival by many years. India, Mexico, Turkey, Jordan, and Costa Rica are locations where CHOP is made available abroad.
CHOP is the most preferred and proven treatment regimen for the management of Non Hodgkin’s Lymphoma. The regimen includes three drugs along with a steroid to enhance effectiveness in management of the condition. The name CHOP is derived from Cyclophosphamide, Hydroxydoxorubicin (doxorubicin), Vincristine (Oncovin), Prednisone.
The CHOP treatment is given in the form of cycles each lasting for approximately four weeks. Ideally, a minimum of six cycles of treatment would be required, however the exact number depends upon several considerations including the number of glands involved and the age of the concerned person. The doses are calculated based on the approximate body surface area in square meters. This is done using a table which estimates the body area based on factors like the weight and height of an individual.
Vincristine and Adriamycin are given along with an intravenous drip of normal saline (salt water).
Cyclophosphamide is given either through the oral or the intravenous route depending upon the convenience of the patient and the medical team.
Prednisone is administered orally.
There are certain guidelines which ought to be followed while being treated with the prescribed drug regimen:
Common side-effects of CHOP in management of Non Hodgkin’s Lymphoma
CHOP like any other chemotherapy treatment presents several side effects. The intensity of these side effects depends on the dose and individual reactivity to the drugs. The common side effects include:
Several clinical trial studies have been conducted to review the effectiveness of CHOP regimen with other intensive chemotherapy regimens. The findings have all suggested that CHOP continues to be the best available treatment option for patients even in advanced stage of high grade Non-Hodgkin’s lymphoma. Further clinical studies have suggested that CHOP has good prognosis with remissions occurring after seven years or more and survival rates of as high as 55% after ten years.
India is a lucrative medical tourist destination, providing superior medical and health care, coupled with the use of sophisticated surgical equipment by skillful doctors and surgeons. India offers chemotherapy at affordable rates, while not compromising on quality.
Mexico, is a location that has grown in popularity by virtue of being close to the United States, thus reducing the time schedule for the medical trip, and offering high end medical and clinical care.
Costa Rica proffers the CHOP treatment at a fraction of the cost, while not making any concessions with the level of quality. Deft medical personnel and speedy management of cancer patients has made Costa Rica a hot spot for medical tourism.
A preferred location to have medical and surgical practices carried out, Turkey offers excellent medical staff, advanced chemotherapy techniques, and modern equipment. The CHOP regimen is conducted in a speedy and a cost effective manner.
Jordan has come on to the world map as an ideal medical tourist destination. It has been focusing in a big way on medical tourism, providing substantial benefits and advantages in terms of viable fees and advanced technology.
Cyberknife in India
Cyberknife at Anadolu Medical Center, Turkey
Chemotherapy Treatment (CHOP) Abroad
Cyberknife Cancer Radiotherapy Overseas Radical Gastrectomy Surgery Abroad
Mastectomy Surgery Abroad
Total Pelvic Exenteration Abroad
Cervical Cancer Treatment Abroad
Laryngopharyngectomy With Plastic Reconstruction Abroad
Oral Cavity Cancer Treatment Abroad
Bone Marrow Transplant Abroad
Medical Tourism Corporation facilitates affordable Non Hodgkin’s Lymphoma: Chemotherapy Treatment Regimen in Europe (Turkey) and other overseas world-class oncology treatment destinations.